109,600.00
+2,402.00
+(2.24%)
At close: April 15 at 2:25:15 PM GMT-4
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | 39 | 38 | 56 | 51 |
| Avg. Estimate | 43.33B | 47.8B | 204.04B | 251.02B |
| Low Estimate | 42.26B | 45.05B | 187.55B | 172.37B |
| High Estimate | 46.08B | 52.68B | 245.53B | 335B |
| Year Ago Sales | 26.04B | 30.04B | 130.5B | 204.04B |
| Sales Growth (year/est) | 66.39% | 59.13% | 56.36% | 23.02% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVDACL.SN | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | DA Davidson: Neutral to Neutral | 4/14/2025 |
| Maintains | Citigroup: Buy to Buy | 4/11/2025 |
| Maintains | TD Cowen: Buy to Buy | 4/9/2025 |
| Maintains | DA Davidson: Neutral to Neutral | 3/20/2025 |
| Reiterates | Benchmark: Buy to Buy | 3/20/2025 |
| Maintains | Susquehanna: Positive to Positive | 3/19/2025 |